Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Pediatric Delirium
NCT02056171Phase 2Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in delirium, sponsored by Weill Cornell Medicine. Started Mar 2015; status: terminated.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02056171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056171.